Receptor tyrosine kinase MET as potential target of multi-kinase inhibitor and radiosensitizer sorafenib in HNSCC. [electronic resource]
Producer: 20200527Description: 208-215 p. digitalISSN:- 1097-0347
- Carcinoma, Squamous Cell -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Crizotinib -- pharmacology
- ErbB Receptors -- antagonists & inhibitors
- Head and Neck Neoplasms -- drug therapy
- Humans
- Indoles -- pharmacology
- Phosphorylation -- drug effects
- Piperazines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Sorafenib -- pharmacology
- Sulfonamides -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.